Capital Insight Partners’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-11,239
| Closed | -$2.27M | – | 174 |
|
|
2023
Q1 | $2.27M | Buy |
11,239
+198
| +2% | +$40K | 0.53% | 66 |
|
|
2022
Q4 | $2.41M | Buy |
11,041
+136
| +1% | +$29.6K | 0.62% | 57 |
|
|
2022
Q3 | $2.15M | Buy |
10,905
+80
| +0.7% | +$15.7K | 0.58% | 60 |
|
|
2022
Q2 | $2.32M | Buy |
10,825
+503
| +5% | +$108K | 0.54% | 62 |
|
|
2022
Q1 | $2.93M | Buy |
10,322
+1,048
| +11% | +$298K | 0.6% | 58 |
|
|
2021
Q4 | $3.49M | Buy |
9,274
+933
| +11% | +$352K | 0.71% | 49 |
|
|
2021
Q3 | $3.44M | Sell |
8,341
-177
| -2% | -$73K | 0.75% | 42 |
|
|
2021
Q2 | $3.15M | Buy |
8,518
+6
| +0.1% | +$2.22K | 0.71% | 47 |
|
|
2021
Q1 | $2.47M | Sell |
8,512
-34
| -0.4% | -$9.85K | 0.6% | 65 |
|
|
2020
Q4 | $2.14M | Sell |
8,546
-11
| -0.1% | -$2.75K | 0.54% | 72 |
|
|
2020
Q3 | $1.94M | Sell |
8,557
-4
| -0% | -$906 | 0.54% | 68 |
|
|
2020
Q2 | $1.49M | Sell |
8,561
-80
| -0.9% | -$14K | 0.47% | 76 |
|
|
2020
Q1 | $1.09M | Buy |
8,641
+749
| +9% | +$94.6K | 0.58% | 59 |
|
|
2019
Q4 | $1.21M | Buy |
7,892
+172
| +2% | +$26.3K | 0.55% | 54 |
|
|
2019
Q3 | $1.02M | Buy |
7,720
+57
| +0.7% | +$7.55K | 0.89% | 51 |
|
|
2019
Q2 | $1.09M | Buy |
+7,663
| New | +$1.09M | 0.94% | 49 |
|